Aspen Labs
- Company typePrivate
- Founded1847
- HeadquartersNaucalpan De Juárez, Mexico
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Aspen Labs firmographics
Firmographics- Name
- Aspen Labs
- Legal name
- Aspen Labs S.A. de C.V.
- Website
- https://aspenlatam.com
- Company type
- Private
- Founded year
- 1847
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Aspen Labs industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Direct-to-Provider / Clinic Buy-and-Bill Distributors (HLAIAJAM)
- akta.pro secondary industry
- Controlled Substances & Compliance-Focused Pharmaceutical Distributors (HLAIAJAN)
Keywords
Where Aspen Labs is headquartered
LocationHeadquarters
- HQ city
- Naucalpan De Juárez
- HQ country
- Mexico
- HQ region
- Latin America
Offices1 record
Markets served
Aspen Labs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Aspen generates revenue through the manufacture and sale of generic and branded pharmaceutical products across multiple therapeutic categories including alta especialidad (high specialty), men's and women's health, orthopedics, internal medicine, and supplements. The company distributes through direct sales and channel partners across Latin American markets.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Aspen Labs product offering
Product offeringCore offering
Aspen Labs S.A. de C.V. manufactures and supplies branded and generic pharmaceutical products across multiple therapeutic categories including high specialty (oncology and anticoagulants), men's and women's health (hormonal and reproductive health), orthopedics, internal medicine, and supplements. The company operates as the Latin American subsidiary of South African-headquartered Aspen Group, distributing through direct field sales and pharmacy/drug distribution channels across Mexico, Colombia, Chile, Ecuador, Peru, Argentina, and Central America.
Product overview
Aspen Labs is a pharmaceutical company originating from South Africa with operations in 115+ countries, 9,300+ employees, and 170+ years of experience. The company operates as a diversified pharmaceutical portfolio organized across five therapeutic categories: Alta Especialidad (High Specialty) including oncology and anticoagulant treatments such as Dexperum, Purinethol, Myleran, Leukeran, Imuran, Fraxiparine, Arixtra, Agrastat, Perfalgan, IVublak, and Braunolax; Salud Hombre & Mujer (Men & Women's Health) including hormonal and reproductive health products such as Ovestin, Uprosol, Emselex, Sostenon 250, Novial, Metrigen Fuerte, Deca-durabolin, and Aldomet; Ortopedia (Orthopedics) including anti-inflammatory and musculoskeletal products such as Plinart HA, Indocid, and Bevodinix; Medicina Interna (Internal Medicine) including cardiovascular, anti-infective, and other systemic treatments such as Zyloprim, Thevier, Penetrexyl, Nytol, Meticorten, Meticortelone, Lanoxin, and Emla; and Suplementos (Supplements) including Magfor and Ablazor. The company also markets LAPENAX, a clozapine antipsychotic requiring intensive pharmacovigilance monitoring.
Differentiator
Problem solved
Functional benefit
Products and services
- Ovestin Óvulos Pharmaceutical product for women's health, in pessary/suppository form.
- Ovestin Crema Pharmaceutical cream product for women's health.
- Meticorten Corticosteroid pharmaceutical product for internal medicine indications.
- Meticortelone Corticosteroid pharmaceutical product for internal medicine indications.
- Bevodinix Caps. Pharmaceutical capsule product in the orthopedics therapeutic category.
- Bevodinix Gel Pharmaceutical gel product in the orthopedics therapeutic category.
- Perfalgan High-specialty pharmaceutical product (intravenous paracetamol).
- Dexperum High-specialty pharmaceutical product.
- IVublak High-specialty pharmaceutical product distributed by Aspen Labs as authorized distributor in Mexico.
- Braunolax High-specialty pharmaceutical product distributed by Aspen Labs as authorized distributor in Mexico.
- Purinethol Oncologic pharmaceutical product for high specialty indications.
- Myleran Oncologic pharmaceutical product for high specialty indications.
- Leukeran Oncologic pharmaceutical product for high specialty indications.
- Imuran Immunosuppressant pharmaceutical product for high specialty indications.
- Fraxiparine Anticoagulant pharmaceutical product for high specialty indications.
- Arixtra Anticoagulant pharmaceutical product for high specialty indications.
- Agrastat Antiplatelet pharmaceutical product for high specialty indications.
- Uprosol Pharmaceutical product in men's and women's health.
- Emselex Pharmaceutical product in men's and women's health indications.
- Sostenon 250 Androgen pharmaceutical product for men's health.
- Novial Oral contraceptive pharmaceutical product.
- Metrigen Fuerte Pharmaceutical product for women's health indications.
- Deca-durabolin Anabolic pharmaceutical product for men's health.
- Aldomet Antihypertensive pharmaceutical product for women's health indications.
- Plinart HA Hyaluronic acid pharmaceutical product for orthopedic indications.
- Indocid Anti-inflammatory pharmaceutical product for orthopedic indications.
- Zyloprim Pharmaceutical product for internal medicine indications (gout/uric acid management).
- Thevier Pharmaceutical product in internal medicine category.
- Penetrexyl Pharmaceutical product in internal medicine category.
- Nytol Sleep-aid pharmaceutical product in internal medicine category.
- Lanoxin Cardiovascular pharmaceutical product (digoxin) for internal medicine indications.
- Emla Parches Topical anesthetic patch pharmaceutical product.
- Emla Crema Topical anesthetic cream pharmaceutical product.
- Magfor Supplement containing magnesium, collagen, vitamin C, and vitamin D3 in capsule form with 30 capsules per box.
- Ablazor Hydrolyzed collagen peptide supplement with vitamin C and vitamin D3 in orange-flavored sachets; uses PEPTAN hydrolyzed collagen manufactured by ROUSSELOT, France.
- LAPENAX (Clozapine) Clozapine 25mg and 100mg antipsychotic medication under intensive pharmacovigilance program; ATC Code N05A H02; prescription-only psychotropic drug List III; available in Argentina.
Companies that use Aspen Labs
Customer profileSegments1 record
Ideal customer profiles2 records
Aspen Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Aspen Labs partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Aspen Labs competitors and assessment
Company assessmentDirect peers
- Laboratorios Liomont: Vertically integrated Mexican pharmaceutical manufacturer with branded generics across multiple therapeutic categories. Comparable in manufacturing footprint, Mexican HCP sales motion, and therapy-area diversification.
- Asofarma: Mexican pharmaceutical firm selling branded specialty and generic products through physician channels. Highly comparable business model — vertically integrated manufacturer-distributor selling to Mexican doctors and pharmacies across specialty therapy areas.
- Eurofarma: Brazilian multinational pharmaceutical manufacturer with deep LATAM presence across branded generics, prescription, and OTC. Closely comparable in being a Latin-American-headquartered vertically integrated pharma serving multiple LATAM countries with broad therapeutic portfolios.
- Genomma Lab: Mexico-based branded-generic pharmaceutical company with broad OTC and prescription presence across LATAM. Directly comparable to Aspen Labs in therapy-area breadth, GTM through pharmacy chains, and Mexican HCP-focused field sales.
Broad incumbents
- Sandoz (Novartis): Global generics and biosimilars business spun out of Novartis. Comparable as a broad incumbent in off-patent small molecules with global manufacturing and hospital-channel distribution.
- Teva Pharmaceutical Industries: Global generics leader with extensive off-patent portfolio, including central-nervous-system and specialty franchises. Comparable as a large-scale generics player with similar legacy molecule exposure (e.g., clozapine-style specialty psychiatry).
- Siegfried Holding: Swiss pharmaceutical manufacturer offering both API production and finished-dose generics globally. Comparable in vertically integrated small-molecule manufacturing and exposure to legacy generic molecules.
- STADA Arzneimittel: European-headquartered generics and specialty pharma company with broad European and emerging-markets footprint. Comparable portfolio of legacy generics, branded specialty, and multi-country distribution.
- Sanofi Mexico: Mexican subsidiary of global pharma major Sanofi, selling branded specialty, vaccines, and established products. Comparable in HCP-facing specialty sales in Mexico and overlap with Aspen's Alta Especialidad and chronic-disease categories.
Regional players
- Cristália: Brazilian pharmaceutical manufacturer strong in anesthetics, psychiatry, and hospital specialty products. Comparable in vertically integrated manufacturing and specialty hospital-channel exposure, though primarily Brazil-anchored.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Aspen Labs social profiles
Digital presenceAspen Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aspen Labs leadership team
Management profileNumber of profiles
Profiles1 record
Aspen Labs subsidiaries and ownership
Company hierarchySubsidiaries1 record
Aspen Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aspen Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aspen Labs
What does Aspen Labs do?
Aspen Labs S.A. de C.V. manufactures and supplies branded and generic pharmaceutical products across multiple therapeutic categories including high specialty (oncology and anticoagulants), men's and women's health (hormonal and reproductive health), orthopedics, internal medicine, and supplements. The company operates as the Latin American subsidiary of South African-headquartered Aspen Group, distributing through direct field sales and pharmacy/drug distribution channels across Mexico, Colombia, Chile, Ecuador, Peru, Argentina, and Central America.
Is Aspen Labs a public or private company?
Aspen Labs is a private company. It is classified as corporate owned and is currently operating.
When was Aspen Labs founded?
Aspen Labs was founded in 1847. It employs 501 to 1,000 people.
Where is Aspen Labs based?
Aspen Labs is headquartered in Naucalpan De Juárez, Mexico, in the Latin America region.
How does Aspen Labs make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Aspen Labs's main competitors?
Direct peers on record are Laboratorios Liomont, Asofarma, Eurofarma and Genomma Lab. Broad incumbents are Sandoz (Novartis), Teva Pharmaceutical Industries, Siegfried Holding, STADA Arzneimittel and Sanofi Mexico. Cristália is listed as a regional player.
Does Aspen Labs have an API?
No public API is recorded for Aspen Labs.
What industry is Aspen Labs in?
Aspen Labs's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAM, Direct-to-Provider / Clinic Buy-and-Bill Distributors, with a secondary code of HLAIAJAN, Controlled Substances & Compliance-Focused Pharmaceutical Distributors. Its NAICS code is 325411 and its SIC code is 2834.